Ethyl piperidinoacetylaminobenzoate

DB16527InvestigationalSmall molecule

Ethyl piperidinoacetylaminobenzoate is a medication indicated for the symptomatic treatment of acute and chronic gastritis. A medication used to treat stomach pain, burning in the throat and stomach, and belching.

Formula / weight: C₁₆H₂₂N₂O₃ · 290.363 g/mol (avg)
Also known as: EPAB · Ethyl p-(piperidinoacetylamino)benzoate · Sulcain · Sulcaine

Resolves to

Compound

UNII6M452G7O1FCAS41653-21-8ChEMBLCHEMBL2106245ChEBI31576

Structure

InChIKeyQLGIFPJNYPWBMQ-UHFFFAOYSA-NSMILESCCOC(=O)C1=CC=C(NC(=O)CN2CCCCC2)C=C1

What you can answer from here — as of March 06, 2025

6Structured indicationsCondition, population, route and combination as fields, not prose

1Marketed productAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Ethyl piperidinoacetylaminobenzoate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account